Zurcher Kantonalbank (Zurich Cantonalbank) Moderna, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Moderna, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 192,306 shares of MRNA stock, worth $6.28 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
192,306
Previous 326,749
41.15%
Holding current value
$6.28 Million
Previous $13.6 Million
59.88%
% of portfolio
0.02%
Previous 0.04%
Shares
20 transactions
Others Institutions Holding MRNA
# of Institutions
857Shares Held
255MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$835 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$815 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$581 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$244 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...